Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K–AKT pathway

Genes Chromosomes and Cancer

Volumn 56, Issue 1, 2017, Pages 11-17

  Volckmar, Anna Lena ^a   Leichsenring, Jonas ^a   Flechtenmacher, Christa ^a   Pfarr, Nicole ^b   Siebolts, Udo ^c   Kirchner, Martina ^a   Budczies, Jan ^d   Bockmayr, Michael ^d   Ridinger, Kathrin ^a   Lorenz, Katja ^a   Herpel, Esther ^a,e   Noske, Aurelia ^b   Weichert, Wilko ^b,e   Klauschen, Frederick ^c   Schirmacher, Peter ^a,e   Penzel, Roland ^a   Endris, Volker ^a   Stenzinger, Albrecht ^a,e,f  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f National Center of Tumor Diseases   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCATTER FACTOR RECEPTOR; CHROMOGRANIN; GNAS PROTEIN, HUMAN; MED12 PROTEIN, HUMAN; MEDIATOR COMPLEX; PIK3CA PROTEIN, HUMAN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR MARKER;

ADENOMATOUS POLYP; ADOLESCENT; ADULT; AGED; ARTICLE; BREAST ADENOMA; DNA EXTRACTION; EXON; FEMALE; GENE; GENE SEQUENCE; GNAS GENE; HUMAN; LACTATING ADENOMA; MAJOR CLINICAL STUDY; MED12 GENE; MIDDLE AGED; MISSENSE MUTATION; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; SEMICONDUCTOR; SIGNAL TRANSDUCTION; SOMATIC MUTATION; YOUNG ADULT; ADENOMA; BREAST TUMOR; CANCER STAGING; FOLLOW UP; GENETICS; HIGH THROUGHPUT SEQUENCING; LACTATION; MUTATION; PATHOLOGY; PROCEDURES; PROGNOSIS; VERY ELDERLY;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CHROMOGRANINS; EXONS; FEMALE; FOLLOW-UP STUDIES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LACTATION; MEDIATOR COMPLEX; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; YOUNG ADULT;

EID: 84982969271     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22396     Document Type: Article

References (46)

1. Azzopardi JG, Salm R. 1984. Ductal adenoma of the breast: A lesion which can mimic carcinoma. J Pathol 144:15–23.
2. Bezić J, Karaman I, Šundov D. 2015. Combined fibroadenoma and tubular adenoma of the breast: Rare presentation that confirms common histogenesis. Breast J 21:309–311.
3. Bleeker FE, Felicioni L, Buttitta F, Lamba S, Cardone L, Rodolfo M, Scarpa A, Leenstra S, Frattini M, Barbareschi M, Grammastro MD, Sciarrotta MG, Zanon C, Marchetti A, Bardelli A. 2008. AKT1(E17K) in human solid tumours. Oncogene 27:5648–5650.
4. Boecker W, Buerger H, Schmitz K, Ellis IA, van Diest PJ, Sinn HP, Geradts J, Diallo R, Poremba C, Herbst H. 2001. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 195:415–421.
5. Boyault S, Drouet Y, Navarro C, Bachelot T, Lasset C, Treilleux I, Tabone E, Puisieux A, Wang Q. 2012. Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes. Breast Cancer Res Treat 132:29–39.
6. de Melo Gagliato D, Jardim DL, Falchook G, Tang C, Zinner R, Wheler JJ, Janku F, Subbiah V, Piha-Paul SA, Fu S, Hess K, Roy-Chowdhuri S, Moulder S, Gonzalez-Angulo AM, Meric-Bernstam F, Hong DS. 2014. Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit. Clin Breast Cancer 14:468–474.
7. Domoto H, Tsuda H, Miyakawa K, Shinoda A, Nanasawa T. 2002. Invasive ductal carcinoma associated with tubular adenoma of the breast. Pathol Int 52:244–248.
8. Dunlap J, Le C, Shukla A, Patterson J, Presnell A, Heinrich MC, Corless CL, Troxell ML. 2010. Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma. Breast Cancer Res Treat 120:409–418.
9. Endris V, Penzel R, Warth A, Muckenhuber A, Schirmacher P, Stenzinger A, Weichert W. 2013. Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing. J Mol Diagn 15:765–775.
10. Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S, Kok CY, Jia M, De T, Teague JW, Stratton MR, McDermott U, Campbell PJ. 2015. COSMIC: Exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res D805–D811.
11. Guray M, Sahin AA. 2006. Benign breast diseases: classification, diagnosis, and management. Oncologist 11:435–449.
12. Hertel BF, Zaloudek C, Kempson RL. 1976. Breast adenomas. Cancer 37:2891–2905.
13. Jahn SW, Kashofer K, Thüringer A, Abete L, Winter E, Eidenhammer S, Viertler C, Tavassoli F, Moinfar F. 2016. Mutation profiling of usual ductal hyperplasia of the breast reveals activating mutations predominantly at different levels of the PI3K/AKT/mTOR pathway. Am J Pathol 186:15–23.
14. James K, Bridger J, Anthony PP. 1988. Breast tumour of pregnancy ('lactating' adenoma). J Pathol 156:37–44.
15. Kang S, Bader AG, Vogt PK. 2005. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 102:802–807.
16. Klauschen F, Heim D, Stenzinger A. 2015. Histological tumor typing in the age of molecular profiling. Pathol Res Pract 211:897–900.
17. Koren S, Reavie L, Couto JP, De Silva D, Stadler MB, Roloff T, Britschgi A, Eichlisberger T, Kohler H, Aina O, Cardiff RD, Bentires-Alj M. 2015. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature 525:114–148.
18. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ. 2012. WHO Classification of Tumours of the Breast, 4th ed. Lyon: IARC Press.
19. Lammie GA, Millis RR. 1989. Ductal adenoma of the breast—A review of fifteen cases. Hum Pathol 20:903–908.
20. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. 1989. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692–696.
21. Lim WK, Ong CK, Tan J, Thike AA, Ng CC, Rajasegaran V, Myint SS, Nagarajan S, Nasir ND, McPherson JR, Cutcutache I, Poore G, Tay ST, Ooi WS, Tan VK, Hartman M, Ong KW, Tan BK, Rozen SG, Tan PH, Tan P, Teh BT. 2014. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet 46:877–880.
22. Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R. (2003) c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Res 63:6272–6281.
23. Maiorano E, Albrizio M. 1995. Tubular adenoma of the breast: An immunohistochemical study of ten cases. Pathol Res Pract 191:1222–1230.
24. Marino-Enriquez A, Fletcher CD. 2014. Shouldn't we care about the biology of benign tumours? Nat Rev Cancer 14:701–702.
25. Matsubayashi RN, Momosaki S, Muranaka T. 2016. Ductal adenoma of breast: Imaging characteristics and radiologic-pathologic correlation of unique findings which reflect “pseudoinvasion”. Breast Cancer 23:597–606.
26. Mishima C, Kagara N, Tanei T, Naoi Y, Shimoda M, Shimomura A, Shimazu K, Kim SJ, Noguchi S. 2015. Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing. Breast Cancer Res Treat 152:305–312.
27. Moross T, Lang AP, Mahoney L. 1983. Tubular adenoma of breast. Arch Pathol Lab Med 107:84–86.
28. Nagasawa S, Maeda I, Fukuda T, Wu W, Hayami R, Kojima Y, Tsugawa K, Ohta T. 2015. MED12 exon 2 mutations in phyllodes tumors of the breast. Cancer Med 4:1117–1121.
29. O'Hayre M, Vazquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S, Gutkind JS. 2013. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer 13:412–424.
30. Onstad M, Stuckey A. 2013. Benign breast disorders. Obstet Gynecol Clin North Am 40:459–473.
31. Persaud V, Talerman A, Jordan R. 1968. Pure adenoma of the breast. Arch Pathol 86:481–483.
32. Pfarr N, Kriegsmann M, Sinn P, Klauschen F, Endris V, Herpel E, Muckenhuber A, Jesinghaus M, Klosterhalfen B, Penzel R, Lennerz JK, Weichert W, Stenzinger A. 2015. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast-implications for tumor biology and pathological diagnosis. Genes Chromosomes Cancer 54:444–452.
33. Pfarr N, Sinn HP, Klauschen F, Flechtenmacher C, Bockmayr M, Ridinger K, von Winterfeld M, Warth A, Lorenz K, Budczies J, Penzel R, Lennerz JK, Endris V, Weichert W, Stenzinger A. 2016. Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma. Genes Chromosomes Cancer 55:113–119.
34. Pfarr N, Penzel R, Klauschen F, Heim D, Brandt R, Kazdal D, Jesinghaus M, Herpel E, Schirmacher P, Warth A, Weichert W, Endris V, Stenzinger A. 2016. Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer—A survey across 822 routine diagnostic cases. Genes Chromosomes Cancer. doi: 10.1002/gcc.22378. [Epub ahead of print]
35. Piscuoglio S, Murray M, Fusco N, Marchia C, Loo FL, Martelotto LG, Schultheis AM, Akram M, Weigelt B, Brogi E, Reis-Filho JS. 2015. MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast. Histopathology 67:719–729.
36. Saglam A, Can B. 2005. Coexistence of lactating adenoma and invasive ductal adenocarcinoma of the breast in a pregnant woman. J Clin Pathol 58:87–89.
37. Saimura M, Anan K, Mitsuyama S, Ono M, Toyoshima S. 2015. Ductal carcinoma in situ arising in tubular adenoma of the breast. Breast Cancer 22:428–431.
38. Salemis NS, Gemenetzis G, Karagkiouzis G, Seretis C, Sapounas K, Tsantilas V, Sambaziotis D, Lagoudianakis E. 2012. Tubular adenoma of the breast: A rare presentation and review of the literature. J Clin Med Res 4:64–67.
39. Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, Dummer R, North J, Pincus L, Ruben B, Rickaby W, D'Arrigo C, Robson A, Bastian BC. 2015. The genetic evolution of melanoma from precursor lesions. N Engl J Med 373:1926–1936.
40. Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VL, Pike T, Simms LA, Young J, James M, Montgomery GW, Appleyard M, Hewett D, Togashi K, Jass JR, Leggett BA. 2006. High prevalence of sessile serrated adenomas with BRAF mutations: A prospective study of patients undergoing colonoscopy. Gastroenterology 131:1400–1407.
41. Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, Carey M, Hu Z, Guan Y, Sahin A, Symmans WF, Pusztai L, Nolden LK, Horlings H, Berns K, Hung MC, van de Vijver MJ, Valero V, Gray JW, Bernards R, Mills GB, Hennessy BT. 2008. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 68:6084–6091.
42. Stenzinger A, Pfarr N, Endris V, Penzel R, Jansen L, Wolf T, Herpel E, Warth A, Klauschen F, Kloor M, Roth W, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M, Weichert W. 2014. Mutations in POLE and survival of colorectal cancer patients—Link to disease stage and treatment. Cancer Med 3:1527–1538.
43. Tan J, Ong CK, Lim WK, Ng CC, Thike AA, Ng LM, Rajasegaran V, Myint SS, Nagarajan S, Thangaraju S, Dey S, Nasir ND, Wijaya GC, Lim JQ, Huang D, Li Z, Wong BH, Chan JY, McPherson JR, Cutcutache I, Poore G, Tay ST, Tan WJ, Putti TC, Ahmad BS, Iau P, Chan CW, Tang AP, Yong WS, Madhukumar P, Ho GH, Tan VK, Wong CY, Hartman M, Ong KW, Tan BK, Rozen SG, Tan P, Tan PH, Teh BT. 2015. Genomic landscapes of breast fibroepithelial tumors. Nat Genet 47:1341–1345.
44. Troxell ML, Levine J, Beadling C, Warrick A, Dunlap J, Presnell A, Patterson J, Shukla A, Olson NR, Heinrich MC, Corless CL. 2010. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast. Mod Pathol 23:27–37.
45. Yoshida M, Sekine S, Ogawa R, Yoshida H, Maeshima A, Kanai Y, Kinoshita T, Ochiai A. 2015. Frequent MED12 mutations in phyllodes tumours of the breast. Br J Cancer 112:1703–1708.
46. Yu JH, Kim MJ, Cho H, Liu HJ, Han SJ, Ahn TG. 2013. Breast diseases during pregnancy and lactation. Obstet Gynecol Sci 56:143–159.